During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Here are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector:
Amgen Inc.
Dividend Yield: 3.29%
Morgan Stanley analyst Terence Flynn maintained an equal-weight rating and cut the price target from $281 to $278 on Feb. 7. This analyst has an accuracy rate of 67%.
RBC Capital analyst Gregory Renza maintained an outperform rating and raised the price target from $303 to $329 on Feb. 7. This analyst has an accuracy rate of 72%.
Recent News: On Feb. 26, Amgen AMGN announced the opening of its manufacturing site in Central Ohio, the newest in its global operations network and the most advanced facility to date.a
Medtronic plc
Dividend Yield: 3.31%
Oppenheimer analyst Steven Lichtman maintained a perform rating and raised the price target from $89 to $92 on Feb. 21. This analyst has an accuracy rate of 73%.
Truist Securities analyst Richard Newitter maintained a hold rating and boosted the price target from $87 to $90 on Feb. 21. This analyst has an accuracy rate of 73%.
Recent News: On Feb. 29, Medtronic MDT filed ITC action against Axonics to stop unauthorized use of Medtronic innovations.
AbbVie Inc.
Dividend Yield: 3.52%
Truist Securities analyst Robyn Karnauskas maintained a buy rating and raised the price target from $180 to $195 on Feb. 6. This analyst has an accuracy rate of 66%.
HSBC analyst Rajesh Kumar downgraded the stock from buy to hold and slashed the price target from $167 to $156 on Dec. 18, 2023. This analyst has an accuracy rate of 68%.
Recent News: On Feb. 28, AbbVie ABBV and OSE Immunotherapeutics entered into strategic partnership to develop a novel monoclonal antibody for the treatment of chronic inflammation. Read more: How pharmaceutical M&A is reshaping health care.
Read Next
